Literature DB >> 4051613

Brown recluse spider bites. A comparison of early surgical excision versus dapsone and delayed surgical excision.

R S Rees, D P Altenbern, J B Lynch, L E King.   

Abstract

In a prospective study, 31 patients with brown recluse spider bites were treated by either immediate surgical excision or with the leukocyte inhibitor, dapsone, followed by delayed surgical excision. Patients were matched for age, gender, and lesion size and were excluded if the typical history and physical findings were not present. In patients treated with immediate surgical excision (N = 14), delayed wound healing (N = 5) and objectional scarring (N = 7) were common complications. However, pretreatment treatment with dapsone reduced the incidence of wound complications (N = 1) and objectional scarring (N = 1) (p less than 0.05), while reducing the need for surgical excision (N = 1). There were no severe drug reactions due to dapsone, although one patient had persistent G.I. upset. Pretreatment with dapsone not only reduced surgical complications but also improved the outcome of patients bitten by the brown recluse spider.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4051613      PMCID: PMC1250983          DOI: 10.1097/00000658-198511000-00020

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  12 in total

1.  Probable cause of necrotic spider bite in the Midwest.

Authors:  J A ATKINS; C W WINGO; W A SODEMAN
Journal:  Science       Date:  1957-07-12       Impact factor: 47.728

2.  Surgical treatment of brown spider bites.

Authors:  F B Hershey; C E Aulenbacher
Journal:  Ann Surg       Date:  1969-08       Impact factor: 12.969

3.  Sulfones and sulfonamides in dermatology today.

Authors:  P G Lang
Journal:  J Am Acad Dermatol       Date:  1979-12       Impact factor: 11.527

4.  Dapsone treatment of a brown recluse bite.

Authors:  L E King; R S Rees
Journal:  JAMA       Date:  1983-08-05       Impact factor: 56.272

Review 5.  Sulfonamides and sulfones in dermatologic therapy.

Authors:  J E Bernstein; A L Lorincz
Journal:  Int J Dermatol       Date:  1981-03       Impact factor: 2.736

6.  Bites by the brown spiders Loxosceles unicolor and Loxosceles arizonica in California and Arizona.

Authors:  F E Russell; W G Waldron; M B Madon
Journal:  Toxicon       Date:  1969-09       Impact factor: 3.033

7.  Do brown recluse spider bites induce pyoderma gangrenosum?

Authors:  R S Rees; J P Fields; L E King
Journal:  South Med J       Date:  1985-03       Impact factor: 0.954

8.  Interaction of brown recluse spider venom on cell membranes: the inciting mechanism?

Authors:  R S Rees; L B Nanney; R A Yates; L E King
Journal:  J Invest Dermatol       Date:  1984-10       Impact factor: 8.551

9.  Management of the brown recluse spider bite.

Authors:  R Rees; R B Shack; E Withers; J Madden; J Franklin; J B Lynch
Journal:  Plast Reconstr Surg       Date:  1981-11       Impact factor: 4.730

10.  Platelet aggregation and sphingomyelinase D activity of a purified toxin from the venom of Loxosceles reclusa.

Authors:  G Kurpiewski; L J Forrester; J T Barrett; B J Campbell
Journal:  Biochim Biophys Acta       Date:  1981-12-18
View more
  3 in total

1.  Insects and spiders: infestations and bites.

Authors:  E W Turgeon
Journal:  Can Fam Physician       Date:  1987-10       Impact factor: 3.275

Review 2.  Acute arthropod envenomation. Incidence, clinical features and management.

Authors:  L S Binder
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 May-Jun

3.  The necrotic venom of the brown recluse spider induces dysregulated endothelial cell-dependent neutrophil activation. Differential induction of GM-CSF, IL-8, and E-selectin expression.

Authors:  K D Patel; V Modur; G A Zimmerman; S M Prescott; T M McIntyre
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.